Role of Scintigraphy in Establishing Optimal Perfusion in Hepatic Arterial Infusion Pump Chemotherapy
Authors:
- 1 February 1989
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 12 (1) , 68-74
Abstract
Since 1982, physicians at the Medical College of Ohio, Toledo, have performed 41 hepatic intraarterial chemotherapy infusion pump implantations for palliative treatment of metastatic liver disease from various primary tumors of the gastrointestinal tract. Radionuclide hepatic arterial pump imaging has proven to be a very reliable, cost-effective, and uncomplicated method of evaluating liver perfusion as it relates to pump function, catheter integrity, and positioning. Confirmation of satisfactory hepatic perfusion is the key to acceptable treatment by this modality. In combination with periodic computed tomography (CT) scanning and CEA determinations, scintigraphy plays a major role in establishing effective therapy and aids in determining causal factors behind treatment failures.Keywords
This publication has 5 references indexed in Scilit:
- Technetium-99m Macroaggregates for the Study of the Distribution of Arterial Infusion Chemotherapy in the LiverClinical Nuclear Medicine, 1987
- Hepatic arterial perfusion scintigraphy with Tc-99m-MAA. Use of a totally implanted drug delivery system.Radiology, 1984
- Changes of arterial blood flow patterns during infusion chemotherapy, as monitored by intra-arterially injected technetium99Tcmmacroaggregated albuminBritish Journal of Radiology, 1984
- TOTALLY IMPLANTED DRUG DELIVERY SYSTEM FOR HEPATIC ARTERIAL CHEMOTHERAPY1981
- RADIONUCLIDE ANGIOGRAPHY TO PREDICT PATIENT RESPONSE TO HEPATIC-ARTERY CHEMOTHERAPY1980